4.6 Article

KIF11, a plus end-directed kinesin, as a key gene in benzo(a) pyrene-induced non-small cell lung cancer

Related references

Note: Only part of the references are listed.
Article Cell Biology

Upregulation of KIF11 in TP53 Mutant Glioma Promotes Tumor Stemness and Drug Resistance

Bin Liu et al.

Summary: KIF11 is upregulated in glioma tumors and negatively correlated with overall survival outcomes; It promotes stemness in glioma cells, cell proliferation, and chemoresistance; KIF11 promotes cell cycle progression by upregulating cyclin expression.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Article Dentistry, Oral Surgery & Medicine

The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer,SNAI1, in head and neck carcinoma

Houyu Zhao et al.

Summary: SNAI1 overexpression in head and neck carcinoma tissues may be associated with metastatic lymph node numbers and predict poor outcomes. The expression of SNAI1 is positively correlated with infiltration of diverse immune cells, such as B cells and macrophages, suggesting a potential role in lymph node metastasis and prognosis in HNC.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)

Article Oncology

Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker

Xiao-Cong Mo et al.

Summary: Through analyzing data sets, 141 genes associated with the progression and carcinogenesis of bladder cancer were identified, with KIF11 being one of the most important prognostic biomarkers. The results indicate that KIF11 is significantly upregulated in bladder cancer and may serve as a candidate marker for prognosis, providing insights into investigating the molecular mechanisms of bladder cancer.

ONCOLOGY LETTERS (2021)

Article Oncology

KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo

Gerhard Jungwirth et al.

Summary: The KIF11 inhibitors filanesib and ispinesib have significant anti-tumor effects on aggressive meningiomas, inhibiting tumor growth, inducing apoptosis, and demonstrating good efficacy in a mouse model. Both drugs induce minor hematological side effects, with filanesib showing less pronounced side effects.

CANCER LETTERS (2021)

Article Engineering, Environmental

Epigenome-wide DNA methylation signature of benzo[a]pyrene exposure and their mediation roles in benzo[a]pyrene-associated lung cancer development

Hua Meng et al.

Summary: This study identified 15 CpG sites associated with BPDE-Alb adducts, with methylation levels at 5 sites mediating the association between BPDE-Alb adducts and lung cancer risk. The addition of these CpG sites improved the discrimination for lung cancer compared to traditional factors. These results highlight DNA methylation alterations as potential mediators in lung tumorigenesis induced by B[a]P exposure.

JOURNAL OF HAZARDOUS MATERIALS (2021)

Article Biochemistry & Molecular Biology

GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA

Chenwei Li et al.

Summary: GEPIA2021 is a standalone extension of GEPIA, allowing users to perform cell type-level analysis and survival analysis, helping experimental biologists validate hypotheses and explore large datasets.

NUCLEIC ACIDS RESEARCH (2021)

Article Oncology

KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53/GSK3β signaling

Yan Zhou et al.

Summary: Colorectal cancer is a common cancer of the digestive tract, often treated with chemotherapy drugs like oxaliplatin. KIF11, a key protein in cell division, is overexpressed in CRC tissues and its knockdown leads to tumor growth arrest and increased sensitivity to oxaliplatin. This suggests KIF11 could potentially serve as an oncogene and biomarker for assessing chemotherapy sensitivity in CRC.

JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer

Dang Wei et al.

Summary: Proliferation is a significant hallmark of gallbladder cancer, a relatively rare but fatal malignancy. This study identified KIF11 as a major upregulated regulator of proliferation in gallbladder cancer, potentially promoting GBC cell proliferation through the ERBB2/PI3K/AKT signaling pathway. The findings provide insights into the mechanisms underlying GBC cancer development and may contribute to the development of novel diagnostic and therapeutic targets.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis

Guangyan Zhou et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemistry & Molecular Biology

RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma

Chengdi Wang et al.

MOLECULAR CANCER (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Biochemistry & Molecular Biology

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Suhas V. Vasaikar et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Medicine, Research & Experimental

Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms

Lei Chen et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Article Medicine, General & Internal

CT-pathologic correlation in lung adenocarcinoma and squamous cell carcinoma

Jun-Yan Yue et al.

MEDICINE (2018)

Article Mathematical & Computational Biology

cytoHubba: identifying hub objects and sub-networks from complex interactome

Chia-Hao Chin et al.

BMC SYSTEMS BIOLOGY (2014)

Article Biochemistry & Molecular Biology

NCBI GEO: archive for functional genomics data sets-update

Tanya Barrett et al.

NUCLEIC ACIDS RESEARCH (2013)